Related Experiment Video
Updated: Jun 24, 2026
06:43
Esophageal Heat Transfer for Patient Temperature Control and Targeted Temperature Management
Published on: November 21, 2017
[Appendicular thermal therapy for heart failure].
1Faculty of Pharmaceutical Sciences, Department of Medical Pharmacy, Hyogo University of Health Sciences.
Nihon Rinsho. Japanese Journal of Clinical Medicine
|March 14, 2009
Summary
Steam foot baths may improve endothelial function and reduce mitral regurgitation in patients with end-stage heart failure awaiting heart transplantation. This therapy appears safe and beneficial for this patient group.
Area of Science:
- Cardiology
- Cardiovascular Physiology
Context:
- Patients with end-stage heart failure awaiting heart transplantation often experience refractory symptoms.
- Exploring novel, non-invasive therapies is crucial for improving quality of life and clinical outcomes in this population.
Purpose:
- To preliminarily assess the safety and utility of steam foot bath therapy.
- To evaluate the effects of steam foot bath on core body temperature, hemodynamics, arrhythmia burden, mitral regurgitation, and endothelial function.
Summary:
- A preliminary study involving 4 male patients with dilated cardiomyopathy and refractory chronic congestive heart failure was conducted.
- Steam foot bath therapy led to a significant increase in sublingual temperature (p=0.01) and improved endothelial function (p=0.02).
- While blood pressure, heart rate, and ventricular arrhythmias remained unchanged, a trend towards decreased mitral regurgitation was observed (p=0.06).
Impact:
- Steam foot bath therapy demonstrates potential as a safe and beneficial adjunctive treatment for end-stage heart failure patients.
- Improved endothelial function suggests a positive impact on vascular health, which is critical in heart failure management.
- Further research is warranted to confirm these findings in larger cohorts and elucidate the underlying mechanisms.
More Related Videos
06:25Cooling or Warming the Esophagus to Reduce Esophageal Injury During Left Atrial Ablation in the Treatment of Atrial Fibrillation
Published on: March 15, 2020
08:22In vitro Assessment of Myocardial Protection following Hypothermia-Preconditioning in a Human Cardiac Myocytes Model
Published on: October 27, 2020
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Decreased Body Temperature
A decreased body temperature can occur in patients with hypothermia and frostbite. Heat loss with extended cold exposure overpowers the body's ability to create heat, resulting in hypothermia. Core temperature readings help classify hypothermia. Mild hypothermia is temperatures between 32 °C (89.6 °F) and 35°C (95 °F) and is caused by impaired thermoregulation. Moderate hypothermia is temperatures between 28 C (82.4 °F) and 32 °C (89.6 °F) caused by sustained extreme cold exposure, and severe...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
01:30Heart Failure VII: Nursing Interventions
The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:26Heart Failure III: Clinical Manifestations
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...